XENON PHARMACEUTICALS INC's ticker is XENE and the CUSIP is 98420N105. A total of 135 filers reported holding XENON PHARMACEUTICALS INC in Q1 2022. The put-call ratio across all filers is 10.04 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $13,051,893 | +3.5% | 382,305 | +16.8% | 0.01% | +12.5% |
| Q2 2023 | $12,606,017 | +9.6% | 327,344 | +1.8% | 0.01% | 0.0% |
| Q1 2023 | $11,505,232 | +0.1% | 321,465 | +10.2% | 0.01% | 0.0% |
| Q4 2022 | $11,494,909 | +36.2% | 291,786 | -37.6% | 0.01% | +33.3% |
| Q3 2022 | $8,439,431 | +0.3% | 467,668 | +69.0% | 0.01% | 0.0% |
| Q2 2022 | $8,411,000 | +2570.2% | 276,674 | +2591.1% | 0.01% | – |
| Q1 2022 | $315,000 | – | 10,281 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Ghost Tree Capital, LLC | 790,000 | $12,071,000 | 3.53% |
| GREAT POINT PARTNERS LLC | 700,000 | $10,696,000 | 2.49% |
| COMMODORE CAPITAL LP | 579,432 | $8,854,000 | 2.33% |
| ACUTA CAPITAL PARTNERS, LLC | 417,409 | $6,378,000 | 2.25% |
| DAFNA Capital Management LLC | 406,535 | $6,212,000 | 1.65% |
| Tri Locum Partners LP | 264,134 | $4,036,000 | 1.60% |
| Parkman Healthcare Partners LLC | 311,207 | $4,755,000 | 1.20% |
| Ghost Tree Capital, LLC | 250,000 | $3,820,000 | 1.12% |
| Nan Fung Group Holdings Ltd | 197,880 | $3,024,000 | 0.97% |
| BVF INC/IL | 1,571,778 | $24,017,000 | 0.94% |